echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Medical Research Articles > The "National Key Laboratory for antibody drug development" built by Huabei pharmaceutical new drug research and development company passed the expert acceptance organized by the Ministry of science and technology

    The "National Key Laboratory for antibody drug development" built by Huabei pharmaceutical new drug research and development company passed the expert acceptance organized by the Ministry of science and technology

    • Last Update: 2020-04-03
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    On January 13, the Ministry of science and technology organized an acceptance expert group composed of nine experts in the field of drug research and development to carry out the acceptance of the "National Key Laboratory for antibody drug development" built by Huabei Pharmaceutical Group new drug research and Development Co., Ltd Bao Jihong, inspector of science and Technology Department of Hebei Province, attended the acceptance meeting The expert group highly appraised the construction effect of the National Key Laboratory of antibody drug development It is believed that during the five-year construction period of the laboratory, guided by the national strategic objectives and the major scientific and technological needs of biomedicine, the investment in infrastructure and instruments and equipment, the investment in scientific research and development projects, the improvement of laboratory management system and operation mechanism, and the remarkable achievements in the research and development of antibody drug products have been achieved, among which the national first-class new drug "all human anti rabies" The "toxic monoclonal antibody injection" has completed the clinical phase 2 research, and the recombinant human albumin project has entered the clinical phase 3 One class II new drug has been applied for clinical application, and 11 innovative drugs are in the pre clinical research stage It has well completed the construction task goal, and has become a comprehensive R & D platform for basic research of antibody drug application, major product development and industrialization "National Key Laboratory for antibody drug development" is one of the five national key laboratories approved by the Ministry of science and technology of Hebei Province in 2010 Before that, Hebei Province was also approved to build the "National Key Laboratory of coal based low carbon energy" relying on the new Olympic group, the "National Key Laboratory of photovoltaic materials and technology" relying on Yingli group, the "National Key Laboratory of wind power equipment and control" relying on Guodian United Power Technology Co., Ltd., the "new pharmaceutical preparations and The construction projects of four national key laboratories of enterprises have passed the acceptance of the Ministry of science and technology in advance and have been included in the management sequence of national key laboratories of enterprises   
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.